Bank mergers and acquisitions: when scale really pays

After a drought, the market is moving again. Mercer Capital counted 101 announced US bank deals in 2023, 130 in 2024 and 176 by 22 December 2025, the second consecutive annual rise. The 2025 total equated to 3.8% of bank charters at the start of the year, which sits inside the 2% to 4% range that has typically described annual activity since 1990. Deloitte, using a different count, reported 181 banking transactions in 2025. Whatever the method, the direction is the same: the sector has returned to a normal rhythm of consolidation rather than entered an exceptional one.

Value has risen faster than count. Mercer's analysis of deals where pricing was disclosed shows aggregate value of US$4 billion in 2023, US$17 billion in 2024 and US$49 billion in 2025. The largest transaction, Fifth Third's all-stock purchase of Comerica, was reported by Ankura at US$10.9 billion and is designed to create the ninth largest bank in the country. Larger acquirers are now buying mid-sized franchises, which is the segment this briefing addresses, and they are doing so with stronger currencies and more regulatory comfort than a year ago.

Pricing has recovered with it. The average price-to-tangible-book multiple in US bank deals rebounded to 143% in 2025 from 121% in 2024, though it remains below the post-crisis peak of 174% reached in 2018. KPMG notes that regulatory approval timelines have shortened to around 100 days, which removes one of the long-standing frictions. For a chief strategy officer the implication is twofold. Sellers' expectations are rising, and the window in which a well-prepared buyer can move before a competitor is narrowing. Preparation, not opportunism, is now the scarce asset.

For mid-sized banks the market recovery poses a strategic choice rather than a simple opportunity. A board can buy, sell or remain independent, and each course now has a price. Remaining independent is credible only if the bank can fund the technology and compliance investment that larger rivals are spreading across a bigger base. Selling at a multiple above the 2024 level may be attractive, but only if the board has tested the alternatives, including a merger of equals. Buying requires the integration capacity discussed below. The worst outcome is drift: a bank that neither commits to scale nor invests to compete without it.

What to do: build a standing target map ranked by strategic fit rather than by availability, refresh it quarterly, and agree with the board in advance the price ceiling and the integration capacity you can absorb. A buyer that has already decided what it will pay and what it can integrate can act in the 100-day approval environment without improvising.

The structural case for scale is strong and well documented. McKinsey's 2022 analysis found that the largest US banks enjoy efficiency almost three times better than the smallest. The FDIC data show the consolidation underlying that gap: the number of insured institutions fell from 6,182 at the end of 2015 to 5,406 in 2018, 5,002 in 2020, 4,706 in 2022 and 4,336 at the end of 2025. Fewer, larger banks is the established direction, and it explains why boards of sub-scale institutions feel pressure to act or to be acted upon.

The same evidence carries a warning. An efficiency advantage observed across the industry is a statement about banks that have already integrated, invested in shared platforms and standardised their operations. It is not a statement about the first two years after a merger, when two cost bases, two technology estates and two cultures coexist. McKinsey's 2019 work found that banks often capture only 50 to 70 percent of the cost synergies they plan. Scale is therefore a destination, and the question for a board is whether the route to it is funded and sequenced.

Bain's research adds a useful test of strategic intent. It found that 57% of successful deals were preceded by a clearly articulated growth strategy, against only 25% of failed deals. In other words, the deals that work are rarely opportunistic purchases justified afterwards. They are steps in a plan that existed before the target appeared. Bain also noted that in 2023 only 12% of the top 50 US banks were open to or actively pursuing acquisitions, which suggests the buyer universe was thin for a long time and is now rebuilding its muscle.

Frequency also matters. Bain found that firms which do M&A often and consistently earn 7% in total shareholder return per year, on average, compared with about 3% for their less-active peers. We read that as evidence about capability rather than about deals as such. A bank that has integrated several acquisitions has a tested playbook, a trained integration office and credibility with regulators. A first-time acquirer has none of those, and should price the learning cost into its offer or begin with a smaller transaction that builds the muscle before a transformational one.

What to do: write the scale thesis as a testable statement before approaching a target. Name the cost lines that scale will reduce, the volume threshold at which the reduction appears, and the date. If the thesis cannot be falsified in that way, it is a preference rather than a case, and it will not survive the first integration setback.

Investors have become sceptical about bank acquirers. Ankura's review of 2025 activity found that the median day-one decline in an acquirer's share price was 2.46%, that over 63% of transactions triggered an immediate sell-off and that the median time to recover had extended to 20 trading days, a 33% increase on the prior cycle. The market is not rejecting consolidation. It is demanding evidence that the acquirer has priced prudently and has a credible route to earnings recovery.

Mercer Capital's reading of current pricing is consistent: investors want recovery in 2-3 years. Inclusive of after-tax expense saves, acquisition multiples tend to be 6x to 9x pro forma earnings, and for deals with a publicly traded buyer the pay-to-trade multiple sits in the vicinity of 80% to 95%. A buyer paying materially above that range has to explain, in terms an analyst can model, which synergies justify the premium and when they arrive. A deal that cannot meet a 2-3 year payback at the agreed price is effectively asking shareholders to wait for a benefit they cannot see.

The type of deal matters as well as the price. McKinsey found in 2022 that deals to acquire capabilities accounted for 28 percent of transactions, up from 11 percent in 2010-12, and that 71 percent of these were successful compared with an average of 28 percent for all deals. That does not mean every bank should buy a fintech. It means that a deal with a specific capability rationale is easier to execute and easier to defend than a general-purpose combination justified by size alone.

The sell-off also changes the funding arithmetic of stock-financed deals. Where the consideration is paid in the acquirer's shares, a falling share price reduces the effective price received by the seller and can reopen negotiations. Buyers should model the deal at a share price several percent below the pre-announcement level and agree collar mechanics accordingly. Sellers should recognise that headline premium and realised value can diverge, particularly in the 20 trading days that Ankura found are now typical before the acquirer's share price recovers.

What to do: before announcement, draft the analyst presentation. If the first three slides cannot state what is being bought, why it is worth the price and when earnings recover, the thesis is not ready. Brief the largest shareholders on the logic before the market does.

Bank synergies are mostly technology synergies in disguise. McKinsey's 2019 analysis found that IT enables about 70 percent of a bank's cost synergies, and its 2022 work found that 40 to 50 percent of M&A value capture is enabled through technology integration. These are the two most important numbers for any chief strategy officer, because they locate the value. Branch consolidation and headcount reductions are the visible actions, but they are only possible once customer accounts, payments and risk systems sit on a single platform.

The risk is equally concentrated there. McKinsey has seen banks that continued operating on multiple core banking systems more than five years after a deal closed, and it estimates that integration can add incremental costs of 50 to 100 percent to what a bank already spends on IT. A buyer that treats technology as a workstream to be scoped after closing is accepting a synergy forecast it cannot test. The longer two cores run in parallel, the longer duplicate costs, duplicate controls and divided management attention persist.

Early involvement is the consistent remedy. McKinsey recommends bringing the buyer's chief information officer and one or two key IT experts into due diligence early. We would go further and make three decisions a condition of signing: which core platform survives, which vendor contracts have change-of-control or termination costs, and which customer-facing systems must be converted first. Each decision can be taken with limited information, and each materially changes the cost and timing in the synergy model.

Data architecture deserves separate attention from the core ledger. Customer records, risk models, payments and regulatory reporting each rely on data from both banks, and inconsistent definitions can delay conversion even when the core decision is clear. The practical discipline is to agree a target data model before signing and to treat each deviation as a cost with an owner. Banks that skip this step discover it during testing, when the pressure to meet a public conversion date is greatest and the options for correction are fewest and most expensive.

What to do: add a technology integration gate to the board approval process. The board should see a conversion sequence, an estimate of one-time costs with a stated contingency, and a named executive accountable for the platform decision. Without these, the committee is approving a price rather than a plan.

The failure modes of bank integration are well known, yet they recur. McKinsey's 2019 analysis found that winners heavily discount cost synergies envisioned beyond 24 to 30 months. The reason is practical: after that point, the assumptions about staff attrition, systems and market conditions are too uncertain to underwrite. Boards that accept a synergy profile stretching over five years are accepting a number that carries little evidential weight, and analysts will discount it accordingly.

Revenue and loyalty risks are larger than most models assume. Bain describes one recent merger in which the combined bank's Net Promoter Score dropped by 55% in a single quarter. McKinsey's earlier study of 160 mergers found that the average merging company loses 2 to 5 percent of its combined customers, that almost 70 percent of mergers failed to achieve expected revenue synergies, and that about 60 percent delivered planned cost synergies almost totally. That research is dated 2004, but the pattern, reliable cost savings and unreliable revenue gains, remains the working assumption of careful acquirers.

Integration costs are also routinely under-forecast. The same McKinsey study described a bank that underestimated its integration costs by a factor of three. We would not treat that as typical, but it demonstrates the asymmetry: errors in cost estimates tend to run in one direction. A synergy model that assumes full revenue retention and a single-pass conversion has built its optimism into the base case.

Culture and people are the other half of the loyalty risk, and they are measurable. Retention of relationship managers, branch leaders and technology staff in the first year predicts whether customers experience continuity. Boards can ask for monthly reporting on voluntary attrition among the named critical roles, and tie a share of integration-team incentives to retention as well as cost delivery. A synergy programme that cuts the people customers know, before they have been moved to the new systems, destroys the revenue it was meant to protect.

What to do: model the downside explicitly. Run a case with higher attrition, a slipped conversion date and integration costs materially above plan, and check that the deal still clears the payback test. Assign a customer-retention owner for the first two quarters after conversion, with authority over branch, call-centre and digital changes.

Boards often cite funding synergies as the third pillar of a bank deal alongside scale and technology. A larger balance sheet, a more diverse deposit base and better access to wholesale markets can lower the cost of funds and ease capital planning. These effects are plausible, and the movement of mid-sized banks into larger regulatory categories changes the economics. Mercer notes that Fifth Third, once it has acquired Comerica, will become a category IV bank with $116 billion of assets, which changes its regulatory obligations as well as its funding profile.

The difficulty is evidential. The sources we reviewed do not provide a robust, comparable measure of realised funding-cost savings in bank mergers, and we do not think a board should rely on one. The prudent approach is to treat funding benefits as upside that is excluded from the price test, while recognising that regulatory thresholds, liquidity requirements and deposit retention can also impose new costs on a larger combined institution. A funding synergy that depends on retaining deposits is in effect a customer-retention synergy and carries the same risk.

The valuation data support this discipline. If acquisition multiples of 6x to 9x pro forma earnings already include after-tax expense saves, and investors expect recovery within 2-3 years, then funding benefits that arrive later or less certainly are best regarded as margin of safety. They help the deal if they appear and do not damage it if they do not. That is a healthier basis for negotiation than assuming the benefit and paying for it up front.

Capital is a second funding consideration. Larger combined institutions face higher regulatory expectations as they cross thresholds, and the incremental capital, liquidity and compliance cost must be compared with the benefit of scale. This is not an argument against growth. It is an argument for modelling the post-deal regulatory category in the base case, including the cost of the additional resilience, resolution and reporting requirements that apply, rather than discovering them when the application is already filed and the public narrative is fixed.

What to do: ask the finance team to present three versions of the deal: cost synergies only, cost plus revenue, and cost plus revenue plus funding. Approve on the first. Use the others to understand how much you are relying on benefits that sit outside management control.

The European experience is a useful counterpoint for North American boards. BBVA's offer for Banco Sabadell was rejected by shareholders in October 2025, after the two banks had been kept separate for three years. Brussels Signal, reporting the ECB's push for cross-border mergers, notes that cross-border lending to companies within the euro area accounted for only around 16 per cent of total corporate lending. The point is not that European banks lack strategic logic. It is that regulation, politics and national structures can prevent logic from becoming action.

For US and Canadian boards, the lesson runs the other way. The environment is more permissive than for many years, with approvals around 100 days and a growing set of precedents for large acquirers buying regional franchises. In such a setting, the constraint on value creation is internal. The banks that succeed will be those that can integrate at the pace the regulators now allow, rather than those that can merely announce. Capacity for delivery has become the competitive variable.

Our recommendation is that the chief strategy officer should own a single integrated view of the deal across strategy, technology, finance and risk. Fragmented ownership is how technology decisions get deferred, synergy targets drift and customers become the shock absorbers for internal disagreement. A one-page integration thesis, signed by the heads of each function before the board vote, is a modest and effective control.

It is also worth recognising that the 181 transactions Deloitte counted in 2025 were not all alike. Some were strategic combinations of regional franchises; others were small bolt-ons, credit-union acquisitions or portfolio clean-ups. A chief strategy officer should therefore benchmark a proposed deal against the relevant subset, not the headline count. Comparing a transformational merger with a branch-network purchase flatters one and penalises the other, and leads boards to import expectations about speed and synergy that do not fit the transaction in front of them.

What to do: adopt a standard board paper for every acquisition above a defined size. It should contain the scale thesis, the technology decision, the downside case, the payback at the price paid and the named owners. Review it again 12 months after closing and compare outcomes against it.

Karter McKinley supports acquirers and sellers through our M&A and corporate development service: building target maps, testing the scale and technology thesis, and structuring the integration plan before signing. Where a transaction involves regulated activity, we work alongside FCA-authorised and equivalent regulated firms. This briefing is information, not investment advice.